Last updated: July 17, 2026

Application No. 18/802,089

IMMUNOSUPPRESSANT FORMULATIONS

Non-Final OA

Filed

Aug 13, 2024

Priority

Jan 07, 2011 — EU 11150431.2 +4 more

Examiner

ROSENTHAL, ANDREW S

Art Unit

Tech Center

Assignee

Novartis AG

OA Round

1 (Non-Final)

This examiner grants 51% of cases after interview

— +40.6% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 659 resolved cases, 2023–2026

Examiner Intelligence

ROSENTHAL, ANDREW S View full profile →

Grants 51% of resolved cases

Career Allowance Rate

339 granted / 659 resolved

-8.6% vs TC avg

Strong +41% interview lift

Without

With

+40.6%

Interview Lift

resolved cases with interview

Typical timeline

3y 0m

Avg Prosecution

43 currently pending

Career history

699

Total Applications

across all art units

Statute-Specific Performance

§101

0.2%

-39.8% vs TC avg

§103

68.9%

+28.9% vs TC avg

§102

0.9%

-39.1% vs TC avg

§112

1.1%

-38.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 659 resolved cases

Prosecution Timeline

Aug 13, 2024

Application Filed

May 06, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/493,428

Patent 12667627

NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS

2y 8m to grant Granted Jun 30, 2026

16/961,886

Patent 12653837

Use Of Inhaled Nitric Oxide And Oxygen For The Treatment Of Pulmonary Hypertension

5y 11m to grant Granted Jun 16, 2026

18/725,983

Patent 12653784

DETERMINATION OF THE TRAPPED VOLUME OF A LIPOSOME

1y 11m to grant Granted Jun 16, 2026

18/172,242

Patent 12648920

METHODS OF ADMINISTERING GLUTATHIONE PRECURSORS

3y 3m to grant Granted Jun 09, 2026

18/271,621

Patent 12648899

COSMETIC SALTS

2y 11m to grant Granted Jun 09, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

51%

Grant Probability

92%

With Interview (+40.6%)

3y 0m (~1y 1m remaining)

Median Time to Grant

Low

PTA Risk

Based on 659 resolved cases by this examiner. Grant probability derived from career allowance rate.